Researchers have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumour microenvironment, sparing healthy cells.

The 360º FMC is suited for automotive and aero-structure applications, including powertrain, and closure panel fabrication to name a few uses for the solution. September 15, 2016 - Hexagon ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

(10 December 2025 - Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus ("the "Company") on 18 April 2023 and 25 October 2024, where Hexagon Purus Systems USA LLC, a ...

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Hexagon shares rose after the Swedish measurement-technology group said it agreed to sell its design and engineering business to Cadence Design Systems for 2.7 billion euros ($3.15 billion). Shares in ...

Sept 4 (Reuters) - Cadence Design (CDNS.O), opens new tab said on Thursday it will buy the design and engineering business of Stockholm-based Hexagon AB (HEXAb.ST), opens new tab for 2.7 billion euros ...

(Reuters) -Cadence Design said on Thursday it will buy the design and engineering business of Stockholm-based Hexagon AB for 2.7 billion euros ($3.16 billion), to expand its customer base and scale up ...

Hexagon AB has faced slow growth and margin pressure in 2025, but profitable segments and recurring revenue continue to expand. The company’s autonomous solutions unit posted strong double-digit ...